Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Impaired Autophagy in CD11b+ Dendritic Cells Expands CD4+ Regulatory T Cells and Limits Atherosclerosis in Mice.

Clement M, Raffort J, Lareyre F, Tsiantoulas D, Newland S, Lu Y, Masters L, Harrison J, Saveljeva S, Ma MKL, Ozsvar-Kozma M, Lam BYH, Yeo GSH, Binder CJ, Kaser A, Mallat Z.

Circ Res. 2019 Nov 8;125(11):1019-1034. doi: 10.1161/CIRCRESAHA.119.315248. Epub 2019 Oct 15.

PMID:
31610723
2.

Regulating heart repair with cardiac-specific T lymphocytes.

Mallat Z.

J Clin Invest. 2019 Nov 1;129(11):4587-4589. doi: 10.1172/JCI132441.

3.

Beating (T Lymphocyte-driven) Atherosclerosis with BTLA.

Nus M, Mallat Z, Sage A.

Cardiovasc Res. 2019 Jul 11. pii: cvz184. doi: 10.1093/cvr/cvz184. [Epub ahead of print] No abstract available.

PMID:
31297503
4.

Vascular smooth muscle cells in atherosclerosis.

Basatemur GL, Jørgensen HF, Clarke MCH, Bennett MR, Mallat Z.

Nat Rev Cardiol. 2019 Dec;16(12):727-744. doi: 10.1038/s41569-019-0227-9. Epub 2019 Jun 26. Review.

PMID:
31243391
5.

Keeping our hearts 'NEAT'?

Tsiantoulas D, Mallat Z.

Cardiovasc Res. 2019 Nov 1;115(13):1813-1814. doi: 10.1093/cvr/cvz149. No abstract available.

PMID:
31179492
6.

MARK4 (Microtubule Affinity-Regulating Kinase 4)-Dependent Inflammasome Activation Promotes Atherosclerosis-Brief Report.

Clement M, Chen X, Chenoweth HL, Teng Z, Thome S, Newland SA, Harrison J, Yu X, Finigan AJ, Mallat Z, Li X.

Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1645-1651. doi: 10.1161/ATVBAHA.119.312478. Epub 2019 Jun 6.

PMID:
31167564
7.

Dendritic Cell-Derived TSLP Negatively Regulates HIF-1α and IL-1β During Dectin-1 Signaling.

Elder MJ, Webster SJ, Fitzmaurice TJ, Shaunak ASD, Steinmetz M, Chee R, Mallat Z, Cohen ES, Williams DL, Gaston JSH, Goodall JC.

Front Immunol. 2019 May 8;10:921. doi: 10.3389/fimmu.2019.00921. eCollection 2019.

8.

Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice.

Vila-Caballer M, González-Granado JM, Zorita V, Abu Nabah YN, Silvestre-Roig C, Del Monte-Monge A, Molina-Sánchez P, Ait-Oufella H, Andrés-Manzano MJ, Sanz MJ, Weber C, Kremer L, Gutiérrez J, Mallat Z, Andrés V.

J Mol Cell Cardiol. 2019 Jul;132:154-163. doi: 10.1016/j.yjmcc.2019.05.009. Epub 2019 May 21.

PMID:
31121182
9.

B Cell Fcγ Receptor IIb Modulates Atherosclerosis in Male and Female Mice by Controlling Adaptive Germinal Center and Innate B-1-Cell Responses.

Bagchi-Chakraborty J, Francis A, Bray T, Masters L, Tsiantoulas D, Nus M, Harrison J, Broekhuizen M, Leggat J, Clatworthy MR, Espéli M, Smith KGC, Binder CJ, Mallat Z, Sage AP.

Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1379-1389. doi: 10.1161/ATVBAHA.118.312272. Epub 2019 May 16.

10.

Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review.

Zhao TX, Mallat Z.

J Am Coll Cardiol. 2019 Apr 9;73(13):1691-1706. doi: 10.1016/j.jacc.2018.12.083. Review.

PMID:
30947923
11.

Vascular Smooth Muscle Cell Plasticity and Autophagy in Dissecting Aortic Aneurysms.

Clément M, Chappell J, Raffort J, Lareyre F, Vandestienne M, Taylor AL, Finigan A, Harrison J, Bennett MR, Bruneval P, Taleb S, Jørgensen HF, Mallat Z.

Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1149-1159. doi: 10.1161/ATVBAHA.118.311727.

12.

Differential micro-RNA expression in diabetic patients with abdominal aortic aneurysm.

Lareyre F, Clément M, Moratal C, Loyer X, Jean-Baptiste E, Hassen-Khodja R, Chinetti G, Mallat Z, Raffort J.

Biochimie. 2019 Jul;162:1-7. doi: 10.1016/j.biochi.2019.03.012. Epub 2019 Mar 26.

PMID:
30922869
13.

Transforming growth factor β neutralization finely tunes macrophage phenotype in elastase-induced abdominal aortic aneurysm and is associated with an increase of arginase 1 expression in the aorta.

Raffort J, Lareyre F, Clément M, Moratal C, Jean-Baptiste E, Hassen-Khodja R, Burel-Vandenbos F, Bruneval P, Chinetti G, Mallat Z.

J Vasc Surg. 2019 Aug;70(2):588-598.e2. doi: 10.1016/j.jvs.2018.09.045. Epub 2019 Feb 18.

PMID:
30792060
14.

Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth Rates.

Paige E, Clément M, Lareyre F, Sweeting M, Raffort J, Grenier C, Finigan A, Harrison J, Peters JE, Sun BB, Butterworth AS, Harrison SC, Bown MJ, Lindholt JS, Badger SA, Kullo IJ, Powell J, Norman PE, Scott DJA, Bailey MA, Rose-John S, Danesh J, Freitag DF, Paul DS, Mallat Z.

Circ Genom Precis Med. 2019 Feb;12(2):e002413. doi: 10.1161/CIRCGEN.118.002413.

15.

MicroRNA-21 Deficiency Alters the Survival of Ly-6Clo Monocytes in ApoE-/- Mice and Reduces Early-Stage Atherosclerosis-Brief Report.

Chipont A, Esposito B, Challier I, Montabord M, Tedgui A, Mallat Z, Loyer X, Potteaux S.

Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):170-177. doi: 10.1161/ATVBAHA.118.311942.

PMID:
30587001
16.

The role of B cells in atherosclerosis.

Sage AP, Tsiantoulas D, Binder CJ, Mallat Z.

Nat Rev Cardiol. 2019 Mar;16(3):180-196. doi: 10.1038/s41569-018-0106-9. Review.

PMID:
30410107
17.

IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure.

Ghali R, Altara R, Louch WE, Cataliotti A, Mallat Z, Kaplan A, Zouein FA, Booz GW.

Hypertension. 2018 Oct;72(4):818-828. doi: 10.1161/HYPERTENSIONAHA.118.11157. Review. No abstract available. Erratum in: Hypertension. 2019 Mar;73(3):e12.

PMID:
30354724
18.

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial.

Zhao TX, Kostapanos M, Griffiths C, Arbon EL, Hubsch A, Kaloyirou F, Helmy J, Hoole SP, Rudd JHF, Wood G, Burling K, Bond S, Cheriyan J, Mallat Z.

BMJ Open. 2018 Sep 17;8(9):e022452. doi: 10.1136/bmjopen-2018-022452.

19.

Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction.

Tang TT, Li YY, Li JJ, Wang K, Han Y, Dong WY, Zhu ZF, Xia N, Nie SF, Zhang M, Zeng ZP, Lv BJ, Jiao J, Liu H, Xian ZS, Yang XP, Hu Y, Liao YH, Wang Q, Tu X, Mallat Z, Huang Y, Shi GP, Cheng X.

Theranostics. 2018 Aug 10;8(16):4552-4562. doi: 10.7150/thno.24723. eCollection 2018.

20.

Diabetes and aortic aneurysm: current state of the art.

Raffort J, Lareyre F, Clément M, Hassen-Khodja R, Chinetti G, Mallat Z.

Cardiovasc Res. 2018 Nov 1;114(13):1702-1713. doi: 10.1093/cvr/cvy174. Review.

21.

Conflicting vascular and metabolic impact of the IL-33/sST2 axis.

Altara R, Ghali R, Mallat Z, Cataliotti A, Booz GW, Zouein FA.

Cardiovasc Res. 2018 Oct 1;114(12):1578-1594. doi: 10.1093/cvr/cvy166. Review.

PMID:
29982301
22.

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health.

Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, Sovran B, Denis RGP, Dairou J, Cardellini M, Moreno-Navarrete JM, Straub M, Jegou S, McQuitty C, Viel T, Esposito B, Tavitian B, Callebert J, Luquet SH, Federici M, Fernandez-Real JM, Burcelin R, Launay JM, Tedgui A, Mallat Z, Sokol H, Taleb S.

Nat Med. 2018 Aug;24(8):1113-1120. doi: 10.1038/s41591-018-0060-4. Epub 2018 Jun 25.

PMID:
29942089
23.

Unravelling immune cell complexity in atherosclerosis.

Clément M, Mallat Z.

Cardiovasc Res. 2018 Aug 1;114(10):1306-1307. doi: 10.1093/cvr/cvy165. No abstract available.

PMID:
29939223
24.

B Cell-Activating Factor Neutralization Aggravates Atherosclerosis.

Tsiantoulas D, Sage AP, Göderle L, Ozsvar-Kozma M, Murphy D, Porsch F, Pasterkamp G, Menche J, Schneider P, Mallat Z, Binder CJ.

Circulation. 2018 Nov 13;138(20):2263-2273. doi: 10.1161/CIRCULATIONAHA.117.032790.

25.

Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells.

Richardson GD, Sage A, Bennaceur K, Al Zhrany N, Coelho-Lima J, Dookun E, Draganova L, Saretzki G, Breault DT, Mallat Z, Spyridopoulos I.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1283-1296. doi: 10.1161/ATVBAHA.117.309940. Epub 2018 Mar 29.

26.

Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet.

Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A, Mallat Z, Potteaux S, Taleb S.

PLoS One. 2018 Mar 1;13(3):e0193737. doi: 10.1371/journal.pone.0193737. eCollection 2018.

27.

Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21-year cohort.

Chung O, Juonala M, Mallat Z, Hutri-Kähönen N, Viikari JSA, Raitakari OT, Magnussen CG.

J Pediatr (Rio J). 2019 Mar - Apr;95(2):247-254. doi: 10.1016/j.jped.2018.01.002. Epub 2018 Feb 21.

28.

Deletion of IRF8 (Interferon Regulatory Factor 8)-Dependent Dendritic Cells Abrogates Proatherogenic Adaptive Immunity.

Clément M, Haddad Y, Raffort J, Lareyre F, Newland SA, Master L, Harrison J, Ozsvar-Kozma M, Bruneval P, Binder CJ, Taleb S, Mallat Z.

Circ Res. 2018 Mar 16;122(6):813-820. doi: 10.1161/CIRCRESAHA.118.312713. Epub 2018 Feb 7.

PMID:
29436389
29.

Selective EGF-Receptor Inhibition in CD4+ T Cells Induces Anergy and Limits Atherosclerosis.

Zeboudj L, Maître M, Guyonnet L, Laurans L, Joffre J, Lemarie J, Bourcier S, Nour-Eldine W, Guérin C, Friard J, Wakkach A, Fabre E, Tedgui A, Mallat Z, Tharaux PL, Ait-Oufella H.

J Am Coll Cardiol. 2018 Jan 16;71(2):160-172. doi: 10.1016/j.jacc.2017.10.084.

30.

Selective EGFR (Epidermal Growth Factor Receptor) Deletion in Myeloid Cells Limits Atherosclerosis-Brief Report.

Zeboudj L, Giraud A, Guyonnet L, Zhang Y, Laurans L, Esposito B, Vilar J, Chipont A, Papac-Milicevic N, Binder CJ, Tedgui A, Mallat Z, Tharaux PL, Ait-Oufella H.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):114-119. doi: 10.1161/ATVBAHA.117.309927. Epub 2017 Nov 30.

PMID:
29191921
31.

NLRP3 inflammasome pathways in atherosclerosis.

Baldrighi M, Mallat Z, Li X.

Atherosclerosis. 2017 Dec;267:127-138. doi: 10.1016/j.atherosclerosis.2017.10.027. Epub 2017 Oct 22. Review.

32.

Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development.

Nour-Eldine W, Joffre J, Zibara K, Esposito B, Giraud A, Zeboudj L, Vilar J, Terada M, Bruneval P, Vivier E, Ait-Oufella H, Mallat Z, Ugolini S, Tedgui A.

Circ Res. 2018 Jan 5;122(1):47-57. doi: 10.1161/CIRCRESAHA.117.311743. Epub 2017 Oct 18.

PMID:
29046274
33.

The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.

Baylis RA, Gomez D, Mallat Z, Pasterkamp G, Owens GK.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):e174-e177. doi: 10.1161/ATVBAHA.117.310097. Epub 2017 Sep 28. Review. No abstract available.

34.

TGFβ (Transforming Growth Factor-β) Blockade Induces a Human-Like Disease in a Nondissecting Mouse Model of Abdominal Aortic Aneurysm.

Lareyre F, Clément M, Raffort J, Pohlod S, Patel M, Esposito B, Master L, Finigan A, Vandestienne M, Stergiopulos N, Taleb S, Trachet B, Mallat Z.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2171-2181. doi: 10.1161/ATVBAHA.117.309999. Epub 2017 Sep 14.

PMID:
28912363
35.

Plan B (-cell) in atherosclerosis.

Nus M, Tsiantoulas D, Mallat Z.

Eur J Pharmacol. 2017 Dec 5;816:76-81. doi: 10.1016/j.ejphar.2017.09.002. Epub 2017 Sep 4. Review.

PMID:
28882560
36.

Macrophages.

Mallat Z.

Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):e92-e98. doi: 10.1161/ATVBAHA.117.309730. Review. No abstract available.

PMID:
28747459
37.

MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism.

Li X, Thome S, Ma X, Amrute-Nayak M, Finigan A, Kitt L, Masters L, James JR, Shi Y, Meng G, Mallat Z.

Nat Commun. 2017 Jun 28;8:15986. doi: 10.1038/ncomms15986.

38.

Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells.

Ponnuswamy P, Joffre J, Herbin O, Esposito B, Laurans L, Binder CJ, Tedder TF, Zeboudj L, Loyer X, Giraud A, Zhang Y, Tedgui A, Mallat Z, Ait-Oufella H.

Sci Rep. 2017 Jun 23;7(1):4111. doi: 10.1038/s41598-017-04438-6.

39.

Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.

Mitrofan CG, Appleby SL, Nash GB, Mallat Z, Chilvers ER, Upton PD, Morrell NW.

J Biol Chem. 2017 Aug 18;292(33):13714-13726. doi: 10.1074/jbc.M117.778506. Epub 2017 Jun 23.

40.

X-Box Binding Protein-1 Dependent Plasma Cell Responses Limit the Development of Atherosclerosis.

Sage AP, Nus M, Bagchi Chakraborty J, Tsiantoulas D, Newland SA, Finigan AJ, Masters L, Binder CJ, Mallat Z.

Circ Res. 2017 Jul 21;121(3):270-281. doi: 10.1161/CIRCRESAHA.117.310884. Epub 2017 Jun 15.

PMID:
28620068
41.

Secreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development.

Tsiantoulas D, Kiss M, Bartolini-Gritti B, Bergthaler A, Mallat Z, Jumaa H, Binder CJ.

Sci Rep. 2017 Jun 14;7(1):3540. doi: 10.1038/s41598-017-03688-8.

42.

The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice.

Haddad Y, Lahoute C, Clément M, Laurans L, Metghalchi S, Zeboudj L, Giraud A, Loyer X, Vandestienne M, Wain-Hobson J, Esposito B, Potteaux S, Ait-Oufella H, Tedgui A, Mallat Z, Taleb S.

Circ Res. 2017 Jul 21;121(3):234-243. doi: 10.1161/CIRCRESAHA.117.310960. Epub 2017 Jun 12.

PMID:
28607102
43.

Type-2 innate lymphoid cells control the development of atherosclerosis in mice.

Newland SA, Mohanta S, Clément M, Taleb S, Walker JA, Nus M, Sage AP, Yin C, Hu D, Kitt LL, Finigan AJ, Rodewald HR, Binder CJ, McKenzie ANJ, Habenicht AJ, Mallat Z.

Nat Commun. 2017 Jun 7;8:15781. doi: 10.1038/ncomms15781.

44.

Gingival fibroblasts protect against experimental abdominal aortic aneurysm development and rupture through tissue inhibitor of metalloproteinase-1 production.

Giraud A, Zeboudj L, Vandestienne M, Joffre J, Esposito B, Potteaux S, Vilar J, Cabuzu D, Kluwe J, Seguier S, Tedgui A, Mallat Z, Lafont A, Ait-Oufella H.

Cardiovasc Res. 2017 Sep 1;113(11):1364-1375. doi: 10.1093/cvr/cvx110.

PMID:
28582477
45.

The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?

Mallat Z, Ait-Oufella H, Tedgui A.

Circ Res. 2017 May 26;120(11):1718-1720. doi: 10.1161/CIRCRESAHA.116.310371. Review. No abstract available.

46.

Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet.

Nus M, Sage AP, Lu Y, Masters L, Lam BYH, Newland S, Weller S, Tsiantoulas D, Raffort J, Marcus D, Finigan A, Kitt L, Figg N, Schirmbeck R, Kneilling M, Yeo GSH, Binder CJ, de la Pompa JL, Mallat Z.

Nat Med. 2017 May;23(5):601-610. doi: 10.1038/nm.4315. Epub 2017 Apr 17.

PMID:
28414328
47.

Monocytes and macrophages in abdominal aortic aneurysm.

Raffort J, Lareyre F, Clément M, Hassen-Khodja R, Chinetti G, Mallat Z.

Nat Rev Cardiol. 2017 Aug;14(8):457-471. doi: 10.1038/nrcardio.2017.52. Epub 2017 Apr 13. Review.

PMID:
28406184
48.

IL-21 promotes myocardial ischaemia/reperfusion injury through the modulation of neutrophil infiltration.

Wang K, Wen S, Jiao J, Tang T, Zhao X, Zhang M, Lv B, Lu Y, Zhou X, Li J, Nie S, Liao Y, Wang Q, Tu X, Mallat Z, Xia N, Cheng X.

Br J Pharmacol. 2018 Apr;175(8):1329-1343. doi: 10.1111/bph.13781. Epub 2017 Apr 12.

49.

Commentary: Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells.

Maffia P, Döring Y, Biessen EA, Mallat Z.

Front Immunol. 2017 Feb 13;8:140. doi: 10.3389/fimmu.2017.00140. eCollection 2017. No abstract available.

50.

Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.

Sage AP, Mallat Z.

Br J Pharmacol. 2017 Nov;174(22):3926-3939. doi: 10.1111/bph.13700. Epub 2017 Feb 1. Review.

Supplemental Content

Loading ...
Support Center